Abbott
Abbott Laboratories, commonly known as Abbott, is a leading global healthcare company headquartered in the United States. Founded in 1888, Abbott has established a strong presence in various operational regions, including North America, Europe, and Asia. The company operates primarily in the medical devices, diagnostics, nutrition, and pharmaceuticals sectors. Abbott is renowned for its innovative products, such as the FreeStyle Libre glucose monitoring system and Similac infant formula, which set industry standards for quality and effectiveness. With a commitment to advancing health and well-being, Abbott has achieved significant milestones, including the rapid development of COVID-19 testing solutions. As a market leader, Abbott consistently ranks among the top healthcare companies worldwide, recognised for its dedication to research and development, and its ability to deliver cutting-edge solutions that improve patient outcomes.
DitchCarbon Score
How does Abbott's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Abbott's score of 62 is higher than 80% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Abbott's reported carbon emissions
In 2023, Abbott reported total carbon emissions of approximately 411,000,000 kg CO2e from Scope 1 and Scope 2 sources combined. This includes about 207,000,000 kg CO2e from Scope 1 emissions and approximately 204,000,000 kg CO2e from Scope 2 emissions in the United States. Globally, Abbott's emissions for the same year included about 730,000,000 kg CO2e from Scope 1 and 640,000,000 kg CO2e from Scope 2, alongside a significant Scope 3 total of approximately 1,000,000,000 kg CO2e. Abbott has set ambitious climate commitments, aiming to reduce absolute Scope 1 and 2 emissions by 30% by 2030, using 2018 as the baseline year. This target aligns with the Science Based Targets initiative (SBTi) and is part of their broader sustainability strategy. The company also aims for 82% of its suppliers to have science-based targets by 2026, further enhancing its commitment to reducing emissions across its supply chain. In addition to these near-term goals, Abbott has pledged to achieve net-zero emissions by 2050, demonstrating a long-term commitment to sustainability and climate action. The company is actively pursuing various initiatives, including operational energy efficiency, renewable energy purchases, and the electrification of industrial processes, to meet these targets.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2010 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 620,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 648,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | - | - | 000,000,000 | - | - | - | - | 0,000,000,000 | 0,000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Abbott is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
